Product NewsTopoTarget initiates pivotal Phase II trial with Savicol™ for FAP (an inherited pre-disposition to develop colon cancer)
Product NewsHybrigenics acquiert les droits internationaux pour l’inecalcitol, un analogue de vitamine D
Product NewsOxford Immunotec’s T-SPOT.TB is first test to demonstrate accurate diagnosis of latent TB in HIV patients
Product NewsNew Technology for Accelerating Development of Vaccines Against H5N1 Flu Enters Pilot Study at ProImmune